Skip to content
10-Q

Quarterly Report

TETRALOGIC PHARMACEUTICALS CORP

0001558370-16-007907

← back to feed
Filed
Aug 11, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 8, 2016 24.77M sh
Shares Diluted Q2 2016 · Jun 30, 2016 24.77M sh
Shares Diluted Q2 2016 · Jun 30, 2016 24.77M sh
Shares Diluted Q2 2016 · Jun 30, 2015 23.37M sh
Shares Diluted Q2 2016 · Jun 30, 2015 23.12M sh
Cash And Equivalents Q2 2016 · Jun 30, 2016 $8.68M
Cash And Equivalents Q2 2016 · Dec 31, 2015 $15.3M
Cash And Equivalents Q2 2016 · Jun 30, 2015 $12.44M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $13.07M
Stockholders Equity Q2 2016 · Jun 30, 2016 −$22.25M
Stockholders Equity Q2 2016 · Dec 31, 2015 −$5.94M
Current Liabilities Q2 2016 · Jun 30, 2016 $11.9M
Current Liabilities Q2 2016 · Dec 31, 2015 $3.66M
Total Liabilities Q2 2016 · Jun 30, 2016 $73.31M
Total Liabilities Q2 2016 · Dec 31, 2015 $69.96M
Current Assets Q2 2016 · Jun 30, 2016 $9.46M
Current Assets Q2 2016 · Dec 31, 2015 $21.97M
Total Assets Q2 2016 · Jun 30, 2016 $51.06M
Total Assets Q2 2016 · Dec 31, 2015 $64.02M
Eps Diluted Q2 2016 · Jun 30, 2016 −$0.27
Eps Diluted Q2 2016 · Jun 30, 2016 −$0.72
Eps Diluted Q2 2016 · Jun 30, 2015 −$0.51
Eps Diluted Q2 2016 · Jun 30, 2015 −$1.07
Eps Basic Q2 2016 · Jun 30, 2016 −$0.27
Eps Basic Q2 2016 · Jun 30, 2016 −$0.72
Eps Basic Q2 2016 · Jun 30, 2015 −$0.51
Eps Basic Q2 2016 · Jun 30, 2015 −$1.06
Sga Expense Q2 2016 · Jun 30, 2016 $2.38M
Sga Expense Q2 2016 · Jun 30, 2016 $5.35M
Sga Expense Q2 2016 · Jun 30, 2015 $2.88M
Sga Expense Q2 2016 · Jun 30, 2015 $6.02M
Rd Expense Q2 2016 · Jun 30, 2016 $1.5M
Rd Expense Q2 2016 · Jun 30, 2016 $4.8M
Rd Expense Q2 2016 · Jun 30, 2015 $7.71M
Rd Expense Q2 2016 · Jun 30, 2015 $14.16M
Net Income Q2 2016 · Jun 30, 2016 −$6.75M
Net Income Q2 2016 · Jun 30, 2016 −$17.81M
Net Income Q2 2016 · Jun 30, 2015 −$11.87M
Net Income Q2 2016 · Jun 30, 2015 −$24.56M
Operating Income Q2 2016 · Jun 30, 2016 −$5.02M
Operating Income Q2 2016 · Jun 30, 2016 −$14.36M
Operating Income Q2 2016 · Jun 30, 2015 −$11.67M
Operating Income Q2 2016 · Jun 30, 2015 −$22.3M
Revenue Q2 2016 · Jun 30, 2016 $0
Capex Q2 2016 · Jun 30, 2015 $50.47K